These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2715059

  • 1. Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agents.
    Adams GE, Stratford IJ, Godden J, Howells N.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1137-9. PubMed ID: 2715059
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs.
    Chaplin DJ, Acker B, Olive PL.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1131-5. PubMed ID: 2715058
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
    Stratford IJ, Adams GE, Godden J, Nolan J, Howells N, Timpson N.
    Br J Cancer; 1988 Aug; 58(2):122-7. PubMed ID: 3166900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
    Dunn JF, Frostick S, Adams GE, Stratford IJ, Howells N, Hogan G, Radda GK.
    FEBS Lett; 1989 Jun 05; 249(2):343-7. PubMed ID: 2737292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor.
    Jarm T, Sersa G, Miklavcic D.
    Technol Health Care; 2002 Jun 05; 10(5):363-80. PubMed ID: 12368557
    [Abstract] [Full Text] [Related]

  • 13. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
    Stratford IJ, Adams GE, Godden J, Howells N.
    Int J Radiat Biol; 1989 Mar 05; 55(3):411-22. PubMed ID: 2564037
    [Abstract] [Full Text] [Related]

  • 14. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
    Sharma C, Soni A, Gupta A, Verma A, Verma S.
    Am J Obstet Gynecol; 2017 Dec 05; 217(6):687.e1-687.e6. PubMed ID: 28867601
    [Abstract] [Full Text] [Related]

  • 15. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
    Honess DJ, Bleehen NM.
    Br J Radiol; 1985 Jan 05; 58(685):63-72. PubMed ID: 4063642
    [Abstract] [Full Text] [Related]

  • 16. Combination of photodynamic therapy (PDT) and melphalan in experimental tumors.
    Sansom JM, Sutton B, Reeves N, Bradley JK, Wood PJ, Bremner JC, Adams GE, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):463-6. PubMed ID: 8005800
    [Abstract] [Full Text] [Related]

  • 17. Oral nifedipine therapy in the management of severe preeclampsia.
    Kwawukume EY, Ghosh TS.
    Int J Gynaecol Obstet; 1995 Jun 15; 49(3):265-9. PubMed ID: 9764864
    [Abstract] [Full Text] [Related]

  • 18. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
    Aali BS, Nejad SS.
    Acta Obstet Gynecol Scand; 2002 Jan 15; 81(1):25-30. PubMed ID: 11942883
    [Abstract] [Full Text] [Related]

  • 19. Dacarbazine and melphalan. Enhancement by dosage scheduling of the effect in combination treatment on the Harding-Passey melanoma in C3D2F1 mice.
    Hill HZ, Hill GJ, Szramowski J.
    Arch Surg; 1979 Feb 15; 114(2):135-8. PubMed ID: 426619
    [Abstract] [Full Text] [Related]

  • 20. CB 1954 revisited. II. Toxicity and antitumour activity.
    Workman P, Morgan JE, Talbot K, Wright KA, Donaldson J, Twentyman PR.
    Cancer Chemother Pharmacol; 1986 Feb 15; 16(1):9-14. PubMed ID: 3940225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.